Status:
UNKNOWN
Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia
Lead Sponsor:
Assiut University
Conditions:
Chronic Myeloid Leukemia
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Nilotinib vs imatinib in patients with newly diagnosed CML-CP
Detailed Description
Study size is 100 patients in 2 arms 50 patients in nilotinib ttt 50 patients in imatinib ttt
Eligibility Criteria
Inclusion
- chronic phase CML not received treatment
- Pts with no heart disease
- Pts with no abnormal cholesterol level
Exclusion
- Any pts treated before with diff. Treatment
- Pts. With past history of heart problems
- Pts. With abnormal cholesterol level
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03228303
Start Date
December 1 2017
End Date
August 1 2020
Last Update
October 10 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.